Transcatheter management of valvular regurgitation beyond the aortic valve (mitral - tricuspid valve): Literature overview and future perspectives

Hellenic J Cardiol. 2020 Sep-Oct;61(5):299-305. doi: 10.1016/j.hjc.2020.04.016. Epub 2020 May 6.

Abstract

The growth of the available transcatheter treatment approaches for the mitral and tricuspid position was accompanied by important clinical trials and studies through the last years. The selection of appropriate candidates for transcatheter techniques requires significant insight into anatomical limitations of each patient undergoing clinical evaluation. Furthermore, technological characteristics of the available devices, and risks and benefits of each potential therapy, play the most important role in a physician's decision. This knowledge should be valuable to both interventional cardiologists and researchers. This paper aims to offer a concise overview of the technological advances in this field of Interventional Cardiology. Trials and studies announced at the major interventional cardiology congresses during 2018 and 2019 were systematically reviewed. Moreover, a literature search in PubMed for the same period identified an amount of publications eligible for inclusion, based on their relevance to the subject, and their potential impact on current guidelines of good clinical practice.

Keywords: mitral regurgitation; transcatheter techniques; tricuspid regurgitation.

Publication types

  • Systematic Review

MeSH terms

  • Aortic Valve
  • Forecasting
  • Heart Valve Diseases* / surgery
  • Heart Valve Prosthesis Implantation* / adverse effects
  • Humans
  • Mitral Valve
  • Tricuspid Valve / surgery